Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
17.41
+0.15 (0.87%)
At close: Dec 5, 2025, 4:00 PM EST
17.07
-0.34 (-1.95%)
After-hours: Dec 5, 2025, 7:48 PM EST
Monte Rosa Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 20.95 | -72.7 | -135.35 | -108.5 | -73.96 | -35.88 | |
| Depreciation & Amortization | 10.67 | 10.22 | 8.32 | 3.75 | 2.13 | 0.54 | |
| Loss (Gain) From Sale of Assets | -0.06 | - | -0.02 | -0.11 | 0.02 | - | |
| Loss (Gain) From Sale of Investments | -2.93 | -2.95 | -3.78 | -1.95 | - | - | |
| Stock-Based Compensation | 19.03 | 18.13 | 16.67 | 11.66 | 5.2 | 0.35 | |
| Other Operating Activities | -2.34 | -2.1 | -2.1 | 4.81 | 0.96 | 7.68 | |
| Change in Accounts Receivable | -4.37 | 0.33 | 1.9 | -0.19 | - | - | |
| Change in Accounts Payable | 10.21 | 6.25 | 5.76 | -0.74 | -0.71 | 3.44 | |
| Change in Unearned Revenue | 92.66 | 83.38 | 50 | - | - | - | |
| Change in Other Net Operating Assets | 5.32 | 1.44 | 14.81 | -1.2 | 6.99 | 0.82 | |
| Operating Cash Flow | 149.14 | 42 | -43.8 | -92.47 | -59.36 | -23.05 | |
| Capital Expenditures | -4.12 | -3.99 | -19.04 | -12.91 | -9.73 | -3.39 | |
| Sale of Property, Plant & Equipment | - | - | 0.06 | 0.11 | 0.08 | - | |
| Investment in Securities | -63.55 | -40.46 | 107.78 | -206.42 | - | - | |
| Investing Cash Flow | -67.66 | -44.45 | 88.8 | -219.22 | -9.65 | -3.39 | |
| Issuance of Common Stock | 1.34 | 52.53 | 2.61 | 21.45 | 255.79 | - | |
| Other Financing Activities | - | 46.36 | 24.88 | -0.98 | -21.23 | -0.44 | |
| Financing Cash Flow | 1.34 | 98.89 | 27.49 | 20.47 | 377.56 | 60.06 | |
| Net Cash Flow | 82.81 | 96.44 | 72.49 | -291.22 | 308.55 | 33.62 | |
| Free Cash Flow | 145.02 | 38.01 | -62.84 | -105.38 | -69.1 | -26.44 | |
| Free Cash Flow Margin | 79.88% | 50.26% | - | - | - | - | |
| Free Cash Flow Per Share | 1.75 | 0.51 | -1.22 | -2.23 | -2.76 | -17.43 | |
| Levered Free Cash Flow | 48.56 | 81.97 | -53.37 | -72.4 | -61.29 | 7.6 | |
| Unlevered Free Cash Flow | 48.56 | 81.97 | -53.37 | -72.4 | -61.29 | 7.6 | |
| Change in Working Capital | 103.83 | 91.4 | 72.47 | -2.13 | 6.29 | 4.26 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.